We are live on !
Find out more
Globeflex Capital Portfolio holdings
AUM
$783M
Turnover
28.73%
1-Year Est. Return
81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
(+18%)
Cap. Flow
-$22.1M
Cap. Flow % of AUM
Cap. Flow %
-2.82%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$6.96M |
| 2 |
MYR Group
MYRG
|
+$4.57M |
| 3 |
Leonardo DRS
DRS
|
+$4.16M |
| 4 |
Semtech
SMTC
|
+$3.99M |
| 5 |
Everpure Inc
P
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Catalyst Pharmaceutical
CPRX
|
+$11.2M |
| 2 |
Credicorp
BAP
|
+$9.17M |
| 3 |
Nextpower Inc. Common Stock
NXT
|
+$6.93M |
| 4 |
XP
XP
|
+$6.54M |
| 5 |
Sterling Infrastructure
STRL
|
+$5.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.29% |
| 2 | Industrials | 19.78% |
| 3 | Financials | 17.73% |
| 4 | Healthcare | 17.14% |
| 5 | Consumer Discretionary | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Agenus
AGEN
$292M
| $1.28M | 0.16% |
+418,581
| New | +$1.5M |
2026 Q2
0 quarters
|
|
152
SGHC Ltd
SGHC
$5.56B
| $1.27M | 0.16% |
93,358
+850
| +0.9% | +$10.8K |
2024 Q4
6 quarters
|
|
153
Indivior Pharmaceuticals
INDV
$4.28B
| $1.24M | 0.16% |
30,280
| – | – |
2025 Q3
3 quarters
|
|
154
Koppers
KOP
$799M
| $1.22M | 0.16% |
27,190
| – | – |
2017 Q1
37 quarters
|
|
155
Orion Group Holdings
ORN
$350M
| $1.2M | 0.15% |
71,310
| – | – |
2025 Q2
4 quarters
|
|
156
AXIS Capital
AXS
$7.62B
| $1.2M | 0.15% |
11,158
-262
| -2% | -$26.3K |
2024 Q3
7 quarters
|
|
157
Stoneridge
SRI
$167M
| $1.2M | 0.15% |
163,443
-45,406
| -22% | -$312K |
2025 Q2
4 quarters
|
|
158
Third Coast Bancshares
TCBX
$681M
| $1.19M | 0.15% |
29,564
-2,297
| -7% | -$89.5K |
2025 Q1
5 quarters
|
|
159
EverQuote
EVER
$844M
| $1.19M | 0.15% |
49,969
| – | – |
2025 Q2
4 quarters
|
|
160
Qualcomm
QCOM
$178B
| $1.18M | 0.15% |
6,405
| – | – |
2021 Q3
19 quarters
|
|
161
Xeris Biopharma Holdings
XERS
$1.86B
| $1.16M | 0.15% |
145,917
+22,733
| +18% | +$145K |
2024 Q4
6 quarters
|
|
162
Howmet Aerospace
HWM
$83.9B
| $1.15M | 0.15% |
4,292
| – | – |
2024 Q3
7 quarters
|
|
163
Mesa Laboratories
MLAB
$700M
| $1.15M | 0.15% |
11,581
+743
| +7% | +$74.8K |
2026 Q1
1 quarter
|
|
164
VTEX
VTEX
$658M
| $1.14M | 0.15% |
285,953
| – | – |
2026 Q1
1 quarter
|
|
165
First Mid Bancshares
FMBH
$1.38B
| $1.14M | 0.15% |
23,714
| – | – |
2024 Q3
7 quarters
|
|
166
Encompass Health
EHC
$13.4B
| $1.12M | 0.14% |
11,065
| – | – |
2023 Q1
13 quarters
|
|
167
Kingstone Companies
KINS
$292M
| $1.11M | 0.14% |
58,102
-116
| -0.2% | -$1.87K |
2026 Q1
1 quarter
|
|
168
Flexsteel Industries
FLXS
$306M
| $1.1M | 0.14% |
14,806
| – | – |
2025 Q1
5 quarters
|
|
169
Ironwood Pharmaceuticals
IRWD
$575M
| $1.09M | 0.14% |
259,809
| – | – |
2026 Q1
1 quarter
|
|
170
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$886M
| $1.09M | 0.14% |
481,684
+387,108
| +409% | +$723K |
2026 Q1
1 quarter
|
|
171
Vertiv
VRT
$89B
| $1.08M | 0.14% |
3,235
-1,165
| -26% | -$369K |
2023 Q3
11 quarters
|
|
172
Great Southern Bancorp
GSBC
$902M
| $1.08M | 0.14% |
13,796
| – | – |
2019 Q3
27 quarters
|
|
173
Keysight
KEYS
$52.2B
| $1.07M | 0.14% |
3,066
| – | – |
2019 Q2
28 quarters
|
|
174
Energy Services of America
ESOA
$174M
| $1.06M | 0.14% |
+54,775
| New | +$893K |
2026 Q2
0 quarters
|
|
175
Liquidity Services
LQDT
$1.43B
| $1.06M | 0.14% |
27,002
| – | – |
2025 Q1
5 quarters
|
|
Similar funds
Globeflex Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.
- Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
- Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
- Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
- Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
- Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
- Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
- Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.
Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.